-Minyanville

Other Tools: Calculators | My Watchlist | My Portfolio

HOSPIRA, Inc. Add to My Watchlist

(NYSE: HSP)

Detailed Quote

Last Price	46.88 (11.20.09 6:40 PM EST)
Change (%)	-0.23 (-0.49%)
Volume	608,835
Open	46.86
Previous Close	47.11
Day's Range	47.12 - 46.70
Bid / Ask	46.89 / 47.40

Intraday

3 Month

6 Month

1 Year

Average Volume	914,192	Shares Outstanding	162.16M
52-Week Range	21.21 - 48.25	Market Cap	7.6B
P/E Ratio	18.4	Earnings Per Share	2.55
Dividend	N/A	Yield	N/A

Symbol	Last	Change (%)
EL	47.86	+0.00 (+0.00)
FRX	29.57	+0.00 (+0.00)
SHDMF	40.78	+0.00 (+0.00)
HEGIF	7.10	+0.00 (+0.00)
NUACF	19.80	+0.00 (+0.00)

Tue, Oct 27, 2009
	Drug stocks gain; Hospira climbs on earnings Drug stocks gain in early action Tuesday, as shares of health-care-products maker Hospira Inc. rise after its third-quarter-earnings report. - MarketWatch
	BP, Valero, U.S. Steel, Palm and more in focus U.S. stock futures traded around the flat line Tuesday after two consecutive heavy drops, with consumer confidence data on tap. - MarketWatch
Mon, Oct 26, 2009
	Stocks in focus for Tuesday Among the shares expected to see active trade in Tuesday’s session are those of Visa, McKesson and TD Ameritrade. - MarketWatch
Wed, Sep 16, 2009
	MV Boom Box: Bulls Said Knock You Out! Don't call it a comebackI been here for years (months)- L.L. Cool J Mama Said Knock You OutBears continued their frustration today as the "bear market rally" revealed fresh new highs for the year. The S&P 500 was up 1.53% to 1068 closing right on the high of the day. The index has closed higher everyday this week and going back to last week it is up eight of the last nine trading sessions. Last night in his report Bedtime with BTIG Mike O’Rourke Chief Market Strategist from BTIG had this to say about the S&P 500. “For anyone ... - Minyanville
Fri, Aug 28, 2009
	Generic versions of biologic medications coming The days of endless market exclusivity could soon come to an end for the biotech industry if Congress moves forward with plans to finally allow generic biologics on the U.S. market. - MarketWatch
More Featured Content

Fri, Nov 20, 2009
	Analyst Choice Initiates Market Analysis on Healthcare, Technology and Consumer Goods Sectors NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC). - Marketwire
Wed, Nov 18, 2009
	Our Lady of the Lake Connects Infusion Pumps to the EHR to Help Decrease Errors and Improve Care Interoperability Between Devices and the EHR Intended to Improve Accuracy and Optimize Workflow - GlobeNewswire
Mon, Nov 16, 2009
	2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer - PR Newswire
Wed, Nov 11, 2009
	Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps - PR Newswire
Tue, Nov 10, 2009
	Complimentary Research Report on LLY, HSP, IVZ, CVC, IM and BLL by WallStSense.com NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com - Marketwire
More Press Releases

11/11/09		Special Conference Hospira at Credit Suisse Healthcare Conference Archive for HSP
10/27/09		Q3 2009 Earnings Archive for HSP
09/23/09		Special Conference 2009 Global Life Sciences Conference Archive for HSP
07/29/09		Q2 2009 Earnings Archive for HSP
06/03/09		Special Conference Hospira at UBS Global Specialty Pharmaceutical Conference Conference Archive for HSP

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Todd Harrison

Terry Woo

Kevin Depew

Jeff Macke

Andrew Jeffery

Jeffrey Cooper

Dr Janice Dorn

Allan Dodds Frank

John Mauldin

Smita Sadana